{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T07:38:56Z","timestamp":1791617936363,"version":"4.3.4"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["668023"],"award-info":[{"award-number":["668023"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["LSHM18057-SGF"],"award-info":[{"award-number":["LSHM18057-SGF"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016036","name":"Health~Holland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016036","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100025327","name":"SG Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100025327","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mucosalimmunology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mucosal Immunology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.mucimm.2024.09.004","type":"journal-article","created":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T21:50:04Z","timestamp":1727301004000},"page":"76-89","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Combined plasma protein and memory T cell profiling discern IBD-patient-immunotypes related to intestinal disease and treatment outcomes"],"prefix":"10.1016","volume":"18","author":[{"given":"Maud","family":"Heredia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Charrout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renz C.W.","family":"Klomberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine A.","family":"Aardoom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria M.E.","family":"Jongsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polychronis","family":"Kemos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle H.","family":"Hulleman-van Haaften","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastiaan","family":"Tuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisette A.","family":"van Berkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Bley Folly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Calado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Nugteren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ytje","family":"Simons-Oosterhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michail","family":"Doukas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathijs A.","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"van Beek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank M.","family":"Ruemmele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas M.","family":"Croft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Mahfouz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel J.T.","family":"Reinders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna C.","family":"Escher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lissy","family":"de Ridder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janneke N.","family":"Samsom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mucimm.2024.09.004_b0005","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1146\/annurev-immunol-042617-053055","article-title":"Translating Immunology into Therapeutic Concepts for Inflammatory Bowel Disease","volume":"36","author":"Uhlig","year":"2018","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.mucimm.2024.09.004_b0010","doi-asserted-by":"crossref","DOI":"10.3390\/cells9010110","article-title":"Dissecting the Heterogeneity in T-Cell Mediated Inflammation in IBD","volume":"9","author":"Tindemans","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.mucimm.2024.09.004_b0015","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/gut.52.1.65","article-title":"Increased expression of interleukin 17 in inflammatory bowel disease","volume":"52","author":"Fujino","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.mucimm.2024.09.004_b0020","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1002\/ibd.21905","article-title":"Compartmentalized expression of Th1 and Th17 cytokines in pediatric inflammatory bowel diseases","volume":"18","author":"Verdier","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.mucimm.2024.09.004_b0025","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1136\/gut.39.5.684","article-title":"Increased production of tumour necrosis factor-alpha interleukin-1 beta, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease","volume":"39","author":"Reimund","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.mucimm.2024.09.004_b0030","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.4049\/jimmunol.157.3.1261","article-title":"Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5","volume":"157","author":"Fuss","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.mucimm.2024.09.004_b0035","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1097\/MIB.0000000000000811","article-title":"Profiles of Lamina Propria T Helper Cell Subsets Discriminate Between Ulcerative Colitis and Crohn\u02bcs Disease","volume":"22","author":"Li","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.mucimm.2024.09.004_b0040","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1093\/ecco-jcc\/jjad119","article-title":"An Intestinal Th17 Subset is Associated with Inflammation in Crohn's Disease and Activated by Adherent-invasive Escherichia coli","volume":"17","author":"Paroni","year":"2023","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.mucimm.2024.09.004_b0045","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.3389\/fimmu.2019.01177","article-title":"Differential Pathogenic Th17 Profile in Mesenteric Lymph Nodes of Crohn's Disease and Ulcerative Colitis Patients","volume":"10","author":"Bsat","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.mucimm.2024.09.004_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2017.12.007","article-title":"A cellular and molecular view of T helper 17 cell plasticity in autoimmunity","volume":"87","author":"Stadhouders","year":"2018","journal-title":"J Autoimmun"},{"key":"10.1016\/j.mucimm.2024.09.004_b0055","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1126\/science.8016643","article-title":"Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA","volume":"265","author":"Steimle","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.mucimm.2024.09.004_b0060","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1084\/jem.158.3.670","article-title":"Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity","volume":"158","author":"Nathan","year":"1983","journal-title":"J Exp Med"},{"key":"10.1016\/j.mucimm.2024.09.004_b0065","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.mucimm.2023.01.005","article-title":"IL-17-driven induction of Paneth cell antimicrobial functions protects the host from microbiota dysbiosis and inflammation in the ileum","volume":"16","author":"Brabec","year":"2023","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.mucimm.2024.09.004_b0070","doi-asserted-by":"crossref","first-page":"e0029223","DOI":"10.1128\/iai.00292-23","article-title":"IL-17 receptor A functions to help maintain barrier integrity and limit activation of immunopathogenic response to H. pylori infection","volume":"92","author":"Brackman","year":"2024","journal-title":"Infect Immun"},{"key":"10.1016\/j.mucimm.2024.09.004_b0075","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/mi.2016.80","article-title":"IL-17A-mediated neutrophil recruitment limits expansion of segmented filamentous bacteria","volume":"10","author":"Flannigan","year":"2017","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.mucimm.2024.09.004_b0080","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1002\/ibd.21312","article-title":"Strong overexpression of CXCR3 axis components in childhood inflammatory bowel disease","volume":"16","author":"Schroepf","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.mucimm.2024.09.004_b0085","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1023\/B:JOCI.0000018066.46279.6b","article-title":"Increased Expression of CCL20 in Human Inflammatory Bowel Disease","volume":"24","author":"Kaser","year":"2004","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.mucimm.2024.09.004_b0090","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1093\/ibd\/izz322","article-title":"Systemic Inflammatory Protein Profiles Distinguish Irritable Bowel Syndrome (IBS) and Ulcerative Colitis, Irrespective of Inflammation or IBS-Like Symptoms","volume":"26","author":"Moraes","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.mucimm.2024.09.004_b0095","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/apt.16136","article-title":"Machine learning identifies novel blood protein predictors of penetrating and stricturing complications in newly diagnosed paediatric Crohn's disease","volume":"53","author":"Ungaro","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.mucimm.2024.09.004_b0100","article-title":"A role for CXCR3 ligands as biomarkers of post-operative Crohn's disease recurrence","author":"Walshe","year":"2021","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.mucimm.2024.09.004_b0105","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/ecco-jcc\/jjaa230","article-title":"Serum proteomic profiling at diagnosis predicts clinical course, and need for intensification of treatment in inflammatory bowel disease","volume":"15","author":"Kalla","year":"2021","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.mucimm.2024.09.004_b0110","doi-asserted-by":"crossref","DOI":"10.1093\/ecco-jcc\/jjad049","article-title":"Serum immune profiling in pediatric Crohn's disease demonstrates stronger immune modulation with first-line infliximab than conventional therapy and pre-treatment profiles predict clinical response to both treatments","author":"Jongsma","year":"2023","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.mucimm.2024.09.004_b0115","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41385-018-0078-4","article-title":"Frequencies of circulating regulatory TIGIT(+)CD38(+) effector T cells correlate with the course of inflammatory bowel disease","volume":"12","author":"Joosse","year":"2019","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.mucimm.2024.09.004_b0120","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.immuni.2019.05.004","article-title":"The Intestine Harbors Functionally Distinct Homeostatic Tissue-Resident and Inflammatory Th17 Cells","volume":"51","author":"Omenetti","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.mucimm.2024.09.004_b0125","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/s41385-019-0194-9","article-title":"IL-10 signaling in dendritic cells controls IL-1beta-mediated IFNgamma secretion by human CD4(+) T cells: relevance to inflammatory bowel disease","volume":"12","author":"Veenbergen","year":"2019","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.mucimm.2024.09.004_b0130","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1038\/s41591-021-01520-5","article-title":"IL-1-driven stromal-neutrophil interactions define a subset of patients with inflammatory bowel disease that does not respond to therapies","volume":"27","author":"Friedrich","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.mucimm.2024.09.004_b0135","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1189\/jlb.1104694","article-title":"LIGHT enhances the bactericidal activity of human monocytes and neutrophils via HVEM","volume":"79","author":"Heo","year":"2006","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.mucimm.2024.09.004_b0140","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.4049\/jimmunol.164.8.4105","article-title":"LIGHT, a TNF-like molecule, costimulates T cell proliferation and is required for dendritic cell-mediated allogeneic T cell response","volume":"164","author":"Tamada","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.mucimm.2024.09.004_b0145","doi-asserted-by":"crossref","first-page":"22313","DOI":"10.1074\/jbc.M001461200","article-title":"Identification of a novel chemokine (CCL28), which binds CCR10 (GPR2)","volume":"275","author":"Wang","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mucimm.2024.09.004_b0150","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1124\/jpet.107.122762","article-title":"Inhibition of adenosine deaminase attenuates inflammation in experimental colitis","volume":"322","author":"Antonioli","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.mucimm.2024.09.004_b0155","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1053\/j.gastro.2020.07.066","article-title":"Predicting Outcomes in Pediatric Ulcerative Colitis for Management Optimization: Systematic Review and Consensus Statements From the Pediatric Inflammatory Bowel Disease-Ahead Program","volume":"160","author":"Orlanski-Meyer","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mucimm.2024.09.004_b0160","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.4049\/jimmunol.162.4.2347","article-title":"Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways","volume":"162","author":"Laan","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.mucimm.2024.09.004_b0165","doi-asserted-by":"crossref","first-page":"7390","DOI":"10.4049\/jimmunol.181.10.7390","article-title":"Intestinal macrophage\/epithelial cell-derived CCL11\/eotaxin-1 mediates eosinophil recruitment and function in pediatric ulcerative colitis","volume":"181","author":"Ahrens","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.mucimm.2024.09.004_b0170","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1038\/labinvest.2012.141","article-title":"Lack of MMP10 exacerbates experimental colitis and promotes development of inflammation-associated colonic dysplasia","volume":"92","author":"Koller","year":"2012","journal-title":"Lab Invest"},{"key":"10.1016\/j.mucimm.2024.09.004_b0175","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nm.4307","article-title":"Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease","volume":"23","author":"West","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.mucimm.2024.09.004_b0180","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1093\/ibd\/izab032","article-title":"Oncostatin M Is a Biomarker of Diagnosis, Worse Disease Prognosis, and Therapeutic Nonresponse in Inflammatory Bowel Disease","volume":"27","author":"Verstockt","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.mucimm.2024.09.004_b0185","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1053\/j.gastro.2020.04.074","article-title":"Single-Cell Analyses of Colon and Blood Reveal Distinct Immune Cell Signatures of Ulcerative Colitis and Crohn's Disease","volume":"159","author":"Mitsialis","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mucimm.2024.09.004_b0190","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1084\/jem.20130301","article-title":"Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids","volume":"211","author":"Ramesh","year":"2014","journal-title":"J Exp Med"},{"key":"10.1016\/j.mucimm.2024.09.004_b0195","first-page":"840","article-title":"Expression of an mdr gene is associated with a new form of resistance to dexamethasone-induced apoptosis","volume":"7","author":"Bourgeois","year":"1993","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.mucimm.2024.09.004_b0200","first-page":"495","article-title":"Biological roles of hepatocyte growth factor-Met signaling from genetically modified animals","volume":"7","author":"Kato","year":"2017","journal-title":"Biomed Rep"},{"key":"10.1016\/j.mucimm.2024.09.004_b0205","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/MEG.0b013e328346e205","article-title":"Adenosine deaminase activity in patients with Crohn's disease: distinction between active and nonactive disease","volume":"23","author":"Maor","year":"2011","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.mucimm.2024.09.004_b0210","doi-asserted-by":"crossref","first-page":"G1062","DOI":"10.1152\/ajpgi.00162.2004","article-title":"Regulated production of the chemokine CCL28 in human colon epithelium","volume":"287","author":"Ogawa","year":"2004","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.mucimm.2024.09.004_b0215","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1038\/s41467-019-10387-7","article-title":"Mass cytometry reveals systemic and local immune signatures that distinguish inflammatory bowel diseases","volume":"10","author":"Rubin","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.mucimm.2024.09.004_b0220","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/eji.201343524","article-title":"Absence of a role for interleukin-13 in inflammatory bowel disease","volume":"44","author":"Biancheri","year":"2014","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.mucimm.2024.09.004_b0225","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/apt.15485","article-title":"Review article: the genetics of the human leucocyte antigen region in inflammatory bowel disease","volume":"50","author":"Ashton","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.mucimm.2024.09.004_b0230","doi-asserted-by":"crossref","first-page":"1161901","DOI":"10.3389\/fimmu.2023.1161901","article-title":"The chromatin and single-cell transcriptional landscapes of CD4 T cells in inflammatory bowel disease link risk loci with a proinflammatory Th17 cell population","volume":"14","author":"Medina","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.mucimm.2024.09.004_b0235","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/MPG.0000000000000239","article-title":"ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents","volume":"58","author":"Levine","year":"2014","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.mucimm.2024.09.004_b0240","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/gutjnl-2020-322339","article-title":"First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn's disease: an open-label multicentre randomised controlled trial","volume":"71","author":"Jongsma","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.mucimm.2024.09.004_b0245","doi-asserted-by":"crossref","first-page":"e035538","DOI":"10.1136\/bmjopen-2019-035538","article-title":"International prospective observational study investigating the disease course and heterogeneity of paediatric-onset inflammatory bowel disease: the protocol of the PIBD-SETQuality inception cohort study","volume":"10","author":"Aardoom","year":"2020","journal-title":"BMJ Open"}],"container-title":["Mucosal Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933021924000977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933021924000977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T08:17:34Z","timestamp":1778833054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933021924000977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1933021924000977"],"URL":"https:\/\/doi.org\/10.1016\/j.mucimm.2024.09.004","relation":{},"ISSN":["1933-0219"],"issn-type":[{"value":"1933-0219","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined plasma protein and memory T cell profiling discern IBD-patient-immunotypes related to intestinal disease and treatment outcomes","name":"articletitle","label":"Article Title"},{"value":"Mucosal Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mucimm.2024.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of Society for Mucosal Immunology.","name":"copyright","label":"Copyright"}]}}